Brief: Marinus Pharmaceuticals Provides Business Update And Reports Fourth Quarter And Full Year 2023 Financial Results

Marinus Pharmaceuticals

05/03/2024 21:22

March 5 (Reuters) - Marinus Pharmaceuticals Inc
 MRNS.O :
    * MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REPORTS
FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
    * MARINUS PHARMACEUTICALS INC - CASH RUNWAY PROJECTED INTO
Q4 2024
WITH CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS OF $150.3
MILLION AS OF DEC 31, 2023
    * MARINUS PHARMACEUTICALS INC - FULL YEAR 2024 U.S. ZTALMY
NET
PRODUCT REVENUE GUIDANCE OF BETWEEN $32 AND $34 MILLION
    * MARINUS PHARMACEUTICALS INC - PHASE 3 TRUSTTSC TRIAL
APPROXIMATELY 85% ENROLLED WITH TOPLINE DATA NOW EXPECTED IN
FIRST HALF OF Q4 2024

Source text for Eikon:  ID:nBw1TJMLta 
Further company coverage:  MRNS.O